Douglas Earl Martin
- SEC CIK
- 0001362155
In the past year, 2 open-market sale filings worth $103.3K and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.SVP, General Counselas of Aug 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $103.3K
- 2 filings
- Net
- −$103.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Douglas Earl Martin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 (view filing)4:43 PM ET | Aug 21 | 4 days | Douglas Earl MartinSVP, General Counsel | SSale | −29.7K | $2.12 | −$63.0K | −5.7%488.3K after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Douglas Earl MartinSVP, General Counsel | SSale | −22.9K | $1.76 | −$40.3K | −3.9%564.9K after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Douglas Earl MartinSVP, General Counsel | SSale | −6.40K | $1.71 | −$11.0K | −1.1%587.8K after |